High Tide (HITI)
Market Price (7/15/2026): $2.16 | Market Cap: $189.8 MilSector: Consumer Staples | Industry: Drug Retail
High Tide (HITI)
Market Price (7/15/2026): $2.16Market Cap: $189.8 MilSector: Consumer StaplesIndustry: Drug Retail
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 22% Attractive yieldFCF Yield is 7.9% Megatrend and thematic driversMegatrends include Cannabis Market Growth & Legalization. Themes include Cannabis Retail & Distribution, Cannabis E-commerce, and Health & Wellness Cannabis Products. | Weak multi-year price returns2Y Excs Rtn is -28% | Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 64% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -27% Key risksHITI key risks include [1] the sustainability of its discount club model against intense market competition and [2] execution failures tied to its aggressive growth strategy of integrating acquisitions and expanding into new markets. |
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 22% |
| Attractive yieldFCF Yield is 7.9% |
| Megatrend and thematic driversMegatrends include Cannabis Market Growth & Legalization. Themes include Cannabis Retail & Distribution, Cannabis E-commerce, and Health & Wellness Cannabis Products. |
| Weak multi-year price returns2Y Excs Rtn is -28% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 64% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -27% |
| Key risksHITI key risks include [1] the sustainability of its discount club model against intense market competition and [2] execution failures tied to its aggressive growth strategy of integrating acquisitions and expanding into new markets. |
Qualitative Assessment
AI Analysis | Feedback
High Tide (HITI) stock has lost about 5% since 3/31/2026 because of the following key factors:
1. Broader cannabis sector experienced a mixed to negative performance in May 2026, offsetting earlier gains. The broader cannabis equity market, after experiencing "supercharged returns" in April 2026 due to the movement of FDA-approved and state-licensed medical marijuana products to Schedule III, saw a "mixed but overall negative performance" in May 2026, dampening the sector's recovery. This macroeconomic trend likely contributed to High Tide's stock decline, despite company-specific positive developments.
2. Persistent regulatory uncertainty surrounding U.S. federal cannabis reform. While the U.S. Drug Enforcement Administration (DEA) moved certain cannabis products to Schedule III in April 2026, adult-use cannabis remains a Schedule I substance under federal law, and the broader proposal to reschedule all marijuana to Schedule III is still undergoing administrative review. DEA hearings for this broader rescheduling were scheduled to begin on June 29, 2026, indicating ongoing hurdles and a lack of definitive resolution, which can create investor apprehension.
Show more
High Tide (HITI) stock has lost about 5% since 3/31/2026 because of the following key factors:
1. Broader cannabis sector experienced a mixed to negative performance in May 2026, offsetting earlier gains. The broader cannabis equity market, after experiencing "supercharged returns" in April 2026 due to the movement of FDA-approved and state-licensed medical marijuana products to Schedule III, saw a "mixed but overall negative performance" in May 2026, dampening the sector's recovery. This macroeconomic trend likely contributed to High Tide's stock decline, despite company-specific positive developments.
2. Persistent regulatory uncertainty surrounding U.S. federal cannabis reform. While the U.S. Drug Enforcement Administration (DEA) moved certain cannabis products to Schedule III in April 2026, adult-use cannabis remains a Schedule I substance under federal law, and the broader proposal to reschedule all marijuana to Schedule III is still undergoing administrative review. DEA hearings for this broader rescheduling were scheduled to begin on June 29, 2026, indicating ongoing hurdles and a lack of definitive resolution, which can create investor apprehension.
3. High Tide's elevated financing costs and leverage. Despite reporting strong fiscal Q2 2026 results, concerns were noted regarding the company's financial structure. For the six months ended April 30, 2026, finance and other costs rose to $11.34 million, up from $6.30 million in the prior year. The balance sheet also showed convertible debt of $18.76 million and secured debentures of $12.77 million, highlighting a significant leverage profile that could weigh on investor sentiment. High Tide's fiscal Q2 2026 ended on April 30, 2026.
4. Sequential decrease in free cash flow despite overall positive earnings. High Tide generated $1.5 million in free cash flow during fiscal Q2 2026 (period ended April 30, 2026). While positive, this represented a decrease from $4.9 million in the prior year and $2.9 million sequentially from fiscal Q1 2026 (period ended January 31, 2026), primarily due to working capital investments. A sequential decline in free cash flow can be a point of concern for investors, even when the company reports record revenue of $179.3 million and a 73% year-over-year increase in adjusted EBITDA to $13.9 million in the same quarter.
Show less
Stock Movement Drivers
Fundamental Drivers
The -5.7% change in HITI stock from 3/31/2026 to 7/14/2026 was primarily driven by a -11.4% change in the company's P/S Multiple.| (LTM values as of) | 3312026 | 7142026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.29 | 2.16 | -5.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 630 | 671 | 6.6% |
| P/S Multiple | 0.3 | 0.3 | -11.4% |
| Shares Outstanding (Mil) | 88 | 88 | -0.2% |
| Cumulative Contribution | -5.7% |
Market Drivers
3/31/2026 to 7/14/2026| Return | Correlation | |
|---|---|---|
| HITI | -5.7% | |
| Market (SPY) | 15.6% | 30.6% |
| Sector (XLP) | 1.8% | -3.3% |
Fundamental Drivers
The -18.5% change in HITI stock from 12/31/2025 to 7/14/2026 was primarily driven by a -25.4% change in the company's P/S Multiple.| (LTM values as of) | 12312025 | 7142026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.65 | 2.16 | -18.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 568 | 671 | 18.1% |
| P/S Multiple | 0.4 | 0.3 | -25.4% |
| Shares Outstanding (Mil) | 81 | 88 | -7.5% |
| Cumulative Contribution | -18.5% |
Market Drivers
12/31/2025 to 7/14/2026| Return | Correlation | |
|---|---|---|
| HITI | -18.5% | |
| Market (SPY) | 10.6% | 33.5% |
| Sector (XLP) | 8.0% | -4.4% |
Fundamental Drivers
The -6.1% change in HITI stock from 6/30/2025 to 7/14/2026 was primarily driven by a -16.4% change in the company's P/S Multiple.| (LTM values as of) | 6302025 | 7142026 | Change |
|---|---|---|---|
| Stock Price ($) | 2.30 | 2.16 | -6.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 550 | 671 | 22.0% |
| P/S Multiple | 0.3 | 0.3 | -16.4% |
| Shares Outstanding (Mil) | 81 | 88 | -7.9% |
| Cumulative Contribution | -6.1% |
Market Drivers
6/30/2025 to 7/14/2026| Return | Correlation | |
|---|---|---|
| HITI | -6.1% | |
| Market (SPY) | 22.7% | 22.3% |
| Sector (XLP) | 5.2% | 1.1% |
Fundamental Drivers
The 74.2% change in HITI stock from 6/30/2023 to 7/14/2026 was primarily driven by a 52.6% change in the company's Total Revenues ($ Mil).| (LTM values as of) | 6302023 | 7142026 | Change |
|---|---|---|---|
| Stock Price ($) | 1.24 | 2.16 | 74.2% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 440 | 671 | 52.6% |
| P/S Multiple | 0.2 | 0.3 | 34.4% |
| Shares Outstanding (Mil) | 75 | 88 | -15.1% |
| Cumulative Contribution | 74.2% |
Market Drivers
6/30/2023 to 7/14/2026| Return | Correlation | |
|---|---|---|
| HITI | 74.2% | |
| Market (SPY) | 75.6% | 23.3% |
| Sector (XLP) | 21.2% | 10.0% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| HITI Return | 5083% | -64% | 6% | 90% | -14% | -18% | 2559% |
| Peers Return | -4% | -55% | -57% | -13% | -19% | -34% | -91% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 10% | 100% |
Monthly Win Rates [3] | |||||||
| HITI Win Rate | 25% | 42% | 50% | 67% | 42% | 43% | |
| Peers Win Rate | 25% | 27% | 40% | 35% | 35% | 26% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 57% | |
Max Drawdowns [4] | |||||||
| HITI Max Drawdown | -53% | -76% | -42% | -37% | -50% | -22% | |
| Peers Max Drawdown | -78% | -60% | -72% | -56% | -60% | -41% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: TLRY, SNDL, CGC, ACB, OGI.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 7/14/2026 (YTD)
How Low Can It Go
| Event | HITI | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -34.2% | -18.8% |
| % Gain to Breakeven | 52.0% | 23.1% |
| Time to Breakeven | 129 days | 79 days |
| 2024 Yen Carry Trade Unwind | ||
| % Loss | -17.3% | -7.8% |
| % Gain to Breakeven | 21.0% | 8.5% |
| Time to Breakeven | 11 days | 18 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -24.6% | -6.7% |
| % Gain to Breakeven | 32.7% | 7.1% |
| Time to Breakeven | 65 days | 31 days |
| 2020 COVID-19 Crash | ||
| % Loss | -55.8% | -33.7% |
| % Gain to Breakeven | 126.4% | 50.9% |
| Time to Breakeven | 441 days | 140 days |
In The Past
High Tide's stock fell -34.2% during the 2025 US Tariff Shock. Such a loss loss requires a 52.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | HITI | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -34.2% | -18.8% |
| % Gain to Breakeven | 52.0% | 23.1% |
| Time to Breakeven | 129 days | 79 days |
| 2023 SVB Regional Banking Crisis | ||
| % Loss | -24.6% | -6.7% |
| % Gain to Breakeven | 32.7% | 7.1% |
| Time to Breakeven | 65 days | 31 days |
| 2020 COVID-19 Crash | ||
| % Loss | -55.8% | -33.7% |
| % Gain to Breakeven | 126.4% | 50.9% |
| Time to Breakeven | 441 days | 140 days |
In The Past
High Tide's stock fell -34.2% during the 2025 US Tariff Shock. Such a loss loss requires a 52.0% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About High Tide (HITI)
High Tide Inc. (HITI) is a Canada-based company primarily engaged in the cannabis retail business, with operations spanning Canada, Europe, the United States, and other international markets. The company maintains a significant physical retail presence, operating and franchising 115 licensed cannabis stores across Canadian provinces such as Ontario, Alberta, Manitoba, and Saskatchewan as of April 2022. Beyond direct retail, High Tide is also involved in the wholesale distribution of cannabis products.
Complementing its cannabis sales, High Tide designs, manufactures, and distributes a wide array of smoking accessories and cannabis lifestyle products. The company also extends its reach through prominent e-commerce platforms like Grasscity.com and CBDcity.com, facilitating international sales of cannabis-related and CBD products. Furthermore, High Tide leverages its industry expertise by offering data analytics services, catering to a broad base of cannabis consumers and enthusiasts both online and through its extensive retail network.
AI Analysis | Feedback
Like a Starbucks, but for cannabis and smoking accessories.
Imagine a chain of specialized liquor stores, but instead of alcohol, they sell cannabis.
AI Analysis | Feedback
- Cannabis Products: High Tide retails and wholesales a variety of cannabis products in licensed stores and potentially through its e-commerce platforms.
- Smoking Accessories & Cannabis Lifestyle Products: The company designs, manufactures, and distributes various smoking accessories and other products related to the cannabis lifestyle.
- Cannabis Retail Store Operations & Franchising: High Tide operates its own network of licensed retail cannabis stores and also offers franchising opportunities for its retail model.
- Data Analytics Services: The company provides data analytics services, likely related to the cannabis industry or consumer trends.
- E-commerce Platforms: High Tide operates online platforms like Grasscity.com and CBDcity.com for the sale of smoking accessories and CBD products.
AI Analysis | Feedback
High Tide Inc. primarily serves individual consumers across its retail locations and online platforms. Its major customer categories include:
- Recreational Cannabis Consumers: Individuals who purchase various cannabis products, such as flower, edibles, vapes, and concentrates, for adult-use purposes from High Tide's numerous physical retail stores across Canada.
- Cannabis Accessory & Lifestyle Product Buyers: Consumers who purchase smoking accessories (e.g., bongs, pipes, vaporizers, grinders) and other cannabis-related lifestyle products. These sales occur through High Tide's retail locations and its dedicated e-commerce platform, Grasscity.com.
- CBD Product Consumers: Individuals specifically seeking and purchasing CBD-infused products. These customers are served through High Tide's retail stores and its specialized online platform, CBDcity.com.
AI Analysis | Feedback
AI Analysis | Feedback
Raj Grover, Founder, President & Chief Executive Officer
Raj Grover is the Founder, President, and Chief Executive Officer of High Tide. He has established himself as a prominent business strategist and dealmaker in Canada. Mr. Grover founded High Tide and its subsidiary companies Valiant Distribution and Canna Cabana, and also co-founded Famous Brandz. Before founding High Tide, he started his first company at the age of 22 and successfully established and sold several small businesses in Ontario. He then founded Smoker's Corner in 2009, which was the precursor to High Tide. Under his leadership, High Tide has grown significantly through organic growth and strategic acquisitions, becoming Canada's largest cannabis retailer. High Tide went public on the Canadian Securities Exchange in December 2018.
Mayank Mahajan, Chief Financial Officer
Mayank Mahajan joined High Tide as Chief Financial Officer in May 2024. He brings over 15 years of expertise from diverse sectors including financial services, technology, manufacturing, trading, and leasing. Prior to High Tide, Mr. Mahajan held positions at Everyday People Financial Corp, Metamaterial Inc., Jubilant Bhartiya Group (Canada, India and USA), Genpact, and S.P. Nagrath & Co. He is a Chartered Professional Accountant in Canada, a Certified Public Accountant in the United States, and a Chartered Accountant in India. His experience includes overseeing mergers and acquisitions, business integration, debt and equity raises, and leading corporate governance initiatives.
Aman Sood, Chief Operating Officer
Aman Sood serves as the Chief Operating Officer of High Tide. He is a seasoned leader with over two decades of experience in retail sector project management, operations, technology, and cost optimization. Mr. Sood was instrumental in leading the building and management of 25 New Leaf Cannabis retail locations. Following High Tide's acquisition of META Growth in 2020, he oversaw the operations of all High Tide stores and led a strategic shift to transform the company's information and technology systems. He previously served as Senior Director, IT & Retail Operations after the META Growth acquisition and led business development for both New Leaf Cannabis and Meta Growth.
Omar Yar Khan, Chief Communications and Public Affairs Officer
Omar Yar Khan is High Tide's Chief Communications and Public Affairs Officer, a role he was promoted to in January 2023. He initially joined High Tide in January 2021 as Senior Vice President of Corporate and Public Affairs. A seasoned cannabis industry professional, Mr. Khan previously served as the National Cannabis Sector Lead for a leading global communications firm (Hill+Knowlton Strategies). He possesses over 20 years of experience as a political and communications strategist in Canadian federal and provincial politics, including serving as Chief of Staff in various Ontario Ministries. He has actively worked with licensed cannabis producers and retailers to influence public policy changes and build corporate profiles.
AI Analysis | Feedback
Key Risks to High Tide (HITI)
- Regulatory and Legal Risks: High Tide operates in the highly regulated cannabis industry across Canada, Europe, and the United States, making it susceptible to significant regulatory and legal changes. Alterations in the regulative landscape, particularly in emerging markets like Germany and other European countries, as well as evolving regulations concerning cannabis, hemp, and derivative products in North America, could profoundly impact the company's operations, expansion strategies, and overall business viability.
- Underperformance of European Wholesale (Remexian) and E-commerce Segments: High Tide's "side businesses," specifically its European medical cannabis distribution through Remexian and its international e-commerce platforms, represent notable risks. Remexian has experienced "transitory weakness" and "much slower" financial performance than anticipated, while the international e-commerce launch has "trailed expectations," leading to segment losses and weighing on the company's overall earnings.
- Macroeconomic Factors and Cannabis Sector Volatility: The company is exposed to broader macroeconomic risks such as high inflation, which can lead to margin compression, increased labor costs, and higher financing expenses. Additionally, the inherent weakness and volatility within the overall cannabis sector, coupled with potential economic downturns and fluctuations in consumer confidence, could adversely affect discretionary spending on cannabis products and accessories, impacting High Tide's revenue and profitability.
AI Analysis | Feedback
AI Analysis | Feedback
Addressable Markets for High Tide (HITI)
- Canada Cannabis Market: The Canadian adult-use cannabis sales reached C$5.5 billion in the fiscal year ending March 31, 2025. The Canada legal cannabis market size was valued at USD 3.25 billion in 2024 and is projected to grow at a CAGR of 12.0% from 2025 to 2030.
- U.S. Cannabis Market: The U.S. cannabis market size was estimated at USD 38.50 billion in 2024 and is expected to reach USD 44.30 billion in 2025. It is projected to reach USD 428.22 billion by 2032.
- Europe Medical Cannabis Market: The European medical cannabis market was valued at USD 6.06 billion in 2024 and is projected to reach USD 36.2 billion by 2033, growing at a CAGR of 21.97% from 2024 to 2033. In 2025, the Europe medical cannabis market size was valued at USD 3,060.0 million and is projected to reach USD 13,161.29 million by 2034.
- Global Smoking Accessories Market: The global smoking accessories market size was valued at USD 73.8 billion in 2025 and is estimated to reach USD 102.3 billion by 2034. Another estimate places the market size at USD 75.24 billion in 2024, projected to grow to USD 107.09 billion by 2033.
- Global Cannabidiol (CBD) Market: The global cannabidiol (CBD) market size was USD 16.52 billion in 2025 and is projected to grow from USD 24.61 billion in 2026 to USD 382.04 billion by 2034. Other reports indicate the market was valued at $14.6 billion in 2025, projected to grow to $203.4 billion by 2034.
- Global Cannabis Technology Market (including Data Analytics): The global cannabis technology market size was valued at USD 3.87 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 25.3% from 2023 to 2030.
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for High Tide (symbol: HITI) over the next 2-3 years:
- Continued Canadian Retail Expansion: High Tide is pursuing an aggressive strategy of expanding its retail footprint across Canada. The company aims to open an additional 20-30 new Canna Cabana locations annually, with a long-term goal of surpassing 350 stores nationwide. This expansion is primarily driven by organic growth, complemented by evaluations of strategic merger and acquisition opportunities.
- International Market Penetration, particularly in Germany: High Tide has established a significant presence in the German medical cannabis market through its majority stake acquisition of Remexian Pharma GmbH, a major importer and distributor of medical cannabis. The company anticipates increased revenue contributions from its German operations and is actively exploring further international expansion into other large markets, including the United States and the United Kingdom, to diversify its revenue streams.
- Growth of the Cabana Club Loyalty Program and ELITE Membership: The company's innovative discount club model, centered around the Cabana Club loyalty program and its paid ELITE membership tier, is a key driver of customer retention and market share growth. With rapidly increasing membership numbers, this model continues to drive high-volume sales and fosters customer loyalty, which is expected to translate into sustained revenue growth through repeat business and increased customer lifetime value.
- Expansion of Proprietary and White Label Product Portfolio: High Tide is focused on developing and expanding its portfolio of higher-margin proprietary and white label cannabis products. While currently representing a small percentage of total cannabis sales, the company anticipates significant long-term growth in this segment, which will contribute to enhanced gross profit margins and overall revenue.
- Strategic Initiatives in the U.S. CBD and Potential Cannabis Markets: High Tide is strategically exploring opportunities within the evolving U.S. market. This includes leveraging its existing U.S. CBD brands, NuLeaf Naturals and FAB CBD, to capitalize on anticipated federal initiatives such as a potential Medicare pilot program for CBD products. The company also has plans to enter U.S. cannabis markets, possibly utilizing its current distribution networks, in anticipation of future regulatory changes.
AI Analysis | Feedback
Share Repurchases
No significant share repurchases or authorized future share repurchase programs with specified dollar amounts were identified for High Tide (HITI) within the last 3-5 years.
Share Issuance
- In July 2022, High Tide completed a "$10 Million Bought Deal Equity Financing", including the full exercise of an over-allotment option.
- As part of the acquisition of a majority stake in Remexian Pharma GmbH in September 2025, High Tide issued 5,864,373 shares valued at approximately €11.1 million.
- In February 2021, High Tide announced a "bought deal" offering for gross proceeds of approximately $15 million, with an additional $2.25 million from an over-allotment option, intended for new retail store openings, strategic acquisitions, and general corporate purposes.
Inbound Investments
No large strategic investments by third-parties (e.g., private equity firms or strategic partners) into High Tide were identified within the last 3-5 years.
Outbound Investments
- In September 2025, High Tide acquired a 51% interest in Remexian Pharma GmbH, a German medical cannabis importer and wholesaler, for an estimated purchase price of €26.4 million (approximately CAD$42.4 million). High Tide also holds a five-year option to acquire the remaining 49% of Remexian.
- In June 2022, High Tide completed the acquisition of Bud Heaven, adding two retail cannabis stores in Ontario, for CAD$2.8 million. The consideration included 564,092 common shares of High Tide and a CAD$1 million cash payment.
- In July 2021, High Tide acquired Daily High Club, a U.S. online marijuana accessories retailer, for US$10 million. This was paid with US$6.75 million in High Tide shares and US$3.25 million in cash.
- In July 2021, High Tide acquired DankStop, another online marijuana accessories retailer, for $3.85 million in High Tide shares. Earlier in 2021, High Tide also acquired FabCBD for $20.6 million and Smoke Cartel for $8 million.
Capital Expenditures
- High Tide generated $12.0 million in free cash flow in fiscal 2025, demonstrating an ability to fund growth internally while expanding its store footprint and entering the German medical cannabis market.
- Capital expenditures in the 12 months leading up to May 2021 were -$7.20 million. More recently, capital expenditures in a recent quarter (prior to March 2026) totaled -2.9040 million CAD.
- The primary focus of capital expenditures includes organic store expansion in Canada, with 27 new Canna Cabana locations opened in calendar year 2025, reaching the higher end of its target of 20-30 new stores. The company has a long-term goal to exceed 300 locations across Canada. Capital expenditures also support strategic entry into new markets, such as Germany, with the Purecan acquisition requiring minimal capital expenditure.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| Is High Tide Stock Built to Withstand More Downside? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 1.73 |
| Mkt Cap | 0.3 |
| Rev LTM | 496 |
| Op Inc LTM | -30 |
| FCF LTM | -29 |
| FCF 3Y Avg | -35 |
| CFO LTM | -12 |
| CFO 3Y Avg | -20 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 8.4% |
| Rev Chg 3Y Avg | 14.2% |
| Rev Chg Q | 7.3% |
| QoQ Delta Rev Chg LTM | 1.4% |
| Op Inc Chg LTM | 32.2% |
| Op Inc Chg 3Y Avg | 36.0% |
| Op Mgn LTM | -6.3% |
| Op Mgn 3Y Avg | -10.5% |
| QoQ Delta Op Mgn LTM | 0.2% |
| CFO/Rev LTM | -3.9% |
| CFO/Rev 3Y Avg | -6.3% |
| FCF/Rev LTM | -8.2% |
| FCF/Rev 3Y Avg | -11.4% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Bricks-and-Mortar | 565 | 484 | 432 | ||
| E-commerce | 19 | 38 | 56 | ||
| Medical cannabis distribution | 10 | ||||
| Corporate | 0 | 0 | |||
| Retail | 352 | 174 | |||
| Wholesale | 4 | 7 | |||
| Total | 594 | 522 | 488 | 357 | 181 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Bricks-and-Mortar | 23 | 12 | -9 | ||
| Medical cannabis distribution | -2 | ||||
| E-commerce | -35 | -7 | -32 | ||
| Corporate | -24 | -15 | |||
| Retail | -47 | -3 | |||
| Wholesale | -2 | -1 | |||
| Total | -14 | 5 | -41 | -72 | -19 |
| $ Mil | 2020 | 2019 | 2018 |
|---|---|---|---|
| Retail | 0 | -10 | 1 |
| Wholesale | -1 | -3 | -4 |
| Corporate | -6 | -13 | -1 |
| Total | -6 | -26 | -5 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Bricks-and-Mortar | 228 | 204 | 186 | ||
| Medical cannabis distribution | 110 | ||||
| E-commerce | 10 | 42 | 48 | ||
| Corporate | 21 | 15 | |||
| Retail | 241 | 223 | |||
| Wholesale | 12 | 8 | |||
| Total | 349 | 246 | 233 | 275 | 246 |
Price Behavior
| Market Price | $2.16 | |
| Market Cap ($ Bil) | 0.2 | |
| First Trading Date | 05/06/2019 | |
| Distance from 52W High | -45.7% | |
| 50 Days | 200 Days | |
| DMA Price | $2.35 | $2.61 |
| DMA Trend | down | down |
| Distance from DMA | -8.0% | -17.3% |
| 3M | 1YR | |
| Volatility | 48.4% | 51.4% |
| Downside Capture | 165.41 | 100.57 |
| Upside Capture | 77.16 | 65.20 |
| Correlation (SPY) | 31.6% | 22.1% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.70 | 0.77 | 1.12 | 1.03 | 0.93 | 0.90 |
| Up Beta | 0.19 | 0.93 | 1.10 | 1.10 | 0.80 | 0.90 |
| Down Beta | 2.61 | 1.59 | 1.22 | 0.57 | 1.20 | 0.84 |
| Up Capture | -19% | 12% | 77% | 85% | 70% | 88% |
| Bmk +ve Days | 11 | 24 | 40 | 67 | 140 | 429 |
| Stock +ve Days | 7 | 16 | 29 | 54 | 110 | 344 |
| Down Capture | 59% | 72% | 149% | 138% | 100% | 98% |
| Bmk -ve Days | 10 | 17 | 23 | 58 | 112 | 321 |
| Stock -ve Days | 13 | 23 | 31 | 62 | 124 | 363 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with HITI | |
|---|---|---|---|---|
| HITI | -8.1% | 51.4% | 0.00 | - |
| Sector ETF (XLP) | 5.4% | 13.5% | 0.14 | 1.0% |
| Equity (SPY) | 21.7% | 12.6% | 1.28 | 22.0% |
| Gold (GLD) | 20.5% | 27.9% | 0.65 | 17.3% |
| Commodities (DBC) | 27.3% | 18.9% | 1.14 | -7.5% |
| Real Estate (VNQ) | 13.0% | 13.9% | 0.64 | 14.7% |
| Bitcoin (BTCUSD) | -47.0% | 42.7% | -1.37 | 20.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with HITI | |
|---|---|---|---|---|
| HITI | -21.8% | 62.9% | -0.14 | - |
| Sector ETF (XLP) | 6.3% | 13.5% | 0.25 | 13.1% |
| Equity (SPY) | 13.1% | 17.1% | 0.59 | 29.2% |
| Gold (GLD) | 17.2% | 18.4% | 0.76 | 9.0% |
| Commodities (DBC) | 8.6% | 19.5% | 0.33 | 5.5% |
| Real Estate (VNQ) | 2.7% | 18.9% | 0.04 | 21.2% |
| Bitcoin (BTCUSD) | 12.8% | 53.4% | 0.42 | 18.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with HITI | |
|---|---|---|---|---|
| HITI | -21.4% | 71.1% | -0.27 | - |
| Sector ETF (XLP) | 7.0% | 14.8% | 0.34 | 18.0% |
| Equity (SPY) | 15.4% | 17.9% | 0.73 | 29.3% |
| Gold (GLD) | 11.2% | 16.1% | 0.57 | 9.2% |
| Commodities (DBC) | 6.3% | 18.0% | 0.27 | 7.7% |
| Real Estate (VNQ) | 5.0% | 20.7% | 0.21 | 21.4% |
| Bitcoin (BTCUSD) | 57.3% | 66.2% | 0.97 | 18.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Updated 6/3/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| SUMMARY STATS | |||
| # Positive | 0 | 0 | 0 |
| # Negative | 0 | 0 | 0 |
| Median Positive | |||
| Median Negative | |||
| Max Positive | |||
| Max Negative | |||
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 04/30/2026 | 06/15/2026 | 6-K |
| 01/31/2026 | 03/17/2026 | 6-K |
| 10/31/2025 | 01/29/2026 | 40-F |
| 07/31/2025 | 09/15/2025 | 6-K |
| 04/30/2025 | 06/16/2025 | 6-K |
| 01/31/2025 | 03/17/2025 | 6-K |
| 10/31/2024 | 01/29/2025 | 40-F |
| 07/31/2024 | 09/16/2024 | 6-K |
| 04/30/2024 | 06/13/2024 | 6-K |
| 01/31/2024 | 03/15/2024 | 6-K |
| 10/31/2023 | 01/29/2024 | 40-F |
| 04/30/2023 | 06/14/2023 | 6-K |
| 01/31/2023 | 03/17/2023 | 6-K |
| 10/31/2022 | 01/31/2023 | 40-F |
| 07/31/2022 | 09/14/2022 | 6-K |
| 04/30/2022 | 06/14/2022 | 6-K |
| Report Date | Filing Date | Filing |
|---|---|---|
| 04/30/2026 | 06/15/2026 | 6-K |
| 01/31/2026 | 03/17/2026 | 6-K |
| 10/31/2025 | 01/29/2026 | 40-F |
| 07/31/2025 | 09/15/2025 | 6-K |
| 04/30/2025 | 06/16/2025 | 6-K |
| 01/31/2025 | 03/17/2025 | 6-K |
| 10/31/2024 | 01/29/2025 | 40-F |
| 07/31/2024 | 09/16/2024 | 6-K |
| 04/30/2024 | 06/13/2024 | 6-K |
| 01/31/2024 | 03/15/2024 | 6-K |
| 10/31/2023 | 01/29/2024 | 40-F |
| 04/30/2023 | 06/14/2023 | 6-K |
| 01/31/2023 | 03/17/2023 | 6-K |
| 10/31/2022 | 01/31/2023 | 40-F |
| 07/31/2022 | 09/14/2022 | 6-K |
| 04/30/2022 | 06/14/2022 | 6-K |
| 01/31/2022 | 03/17/2022 | 6-K |
| 10/31/2021 | 02/02/2022 | 40-F |
| 07/31/2021 | 09/14/2021 | 6-K |
Industry Resources
| Consumer Staples Resources |
| FoodNavigator |
| Consumer Goods Technology (CGT) |
| Beverage Digest |
| Drug Retail Resources |
| Drug Store News |
| Chain Drug Review |
| Pharmacy Times |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.